Cargando…

Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient

We report a case of a patient who had been on long time valproic acid for treatment of bipolar affective disorder. While being an inpatient, serology ammonia level testing revealed a very high ammonia level despite being asymptomatic. Dual therapy of carnitine and lactulose was provided to the patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiyer, Rohit, Seide, Margaret, Stern, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969522/
https://www.ncbi.nlm.nih.gov/pubmed/27516916
http://dx.doi.org/10.1155/2016/6242314
_version_ 1782445789205757952
author Aiyer, Rohit
Seide, Margaret
Stern, Robert G.
author_facet Aiyer, Rohit
Seide, Margaret
Stern, Robert G.
author_sort Aiyer, Rohit
collection PubMed
description We report a case of a patient who had been on long time valproic acid for treatment of bipolar affective disorder. While being an inpatient, serology ammonia level testing revealed a very high ammonia level despite being asymptomatic. Dual therapy of carnitine and lactulose was provided to the patient for treatment of the hyperammonemia. It should also be noted that, during this treatment, valproic acid was not stopped. Consequently, this case illustrates that patients can present asymptomatically despite very high ammonia levels and hyperammonemia can occur in chronic valproic acid despite not increasing the dose of the medication and psychiatrists do not need to discontinue valproic acid in the presence of elevated levels of ammonia if the patient shows no signs of encephalopathy or delirium.
format Online
Article
Text
id pubmed-4969522
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49695222016-08-11 Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient Aiyer, Rohit Seide, Margaret Stern, Robert G. Case Rep Psychiatry Case Report We report a case of a patient who had been on long time valproic acid for treatment of bipolar affective disorder. While being an inpatient, serology ammonia level testing revealed a very high ammonia level despite being asymptomatic. Dual therapy of carnitine and lactulose was provided to the patient for treatment of the hyperammonemia. It should also be noted that, during this treatment, valproic acid was not stopped. Consequently, this case illustrates that patients can present asymptomatically despite very high ammonia levels and hyperammonemia can occur in chronic valproic acid despite not increasing the dose of the medication and psychiatrists do not need to discontinue valproic acid in the presence of elevated levels of ammonia if the patient shows no signs of encephalopathy or delirium. Hindawi Publishing Corporation 2016 2016-07-19 /pmc/articles/PMC4969522/ /pubmed/27516916 http://dx.doi.org/10.1155/2016/6242314 Text en Copyright © 2016 Rohit Aiyer et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Aiyer, Rohit
Seide, Margaret
Stern, Robert G.
Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title_full Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title_fullStr Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title_full_unstemmed Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title_short Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
title_sort valproic acid induced hyperammonemia in a long time treated patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969522/
https://www.ncbi.nlm.nih.gov/pubmed/27516916
http://dx.doi.org/10.1155/2016/6242314
work_keys_str_mv AT aiyerrohit valproicacidinducedhyperammonemiainalongtimetreatedpatient
AT seidemargaret valproicacidinducedhyperammonemiainalongtimetreatedpatient
AT sternrobertg valproicacidinducedhyperammonemiainalongtimetreatedpatient